{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:20:41Z","timestamp":1787905241425,"version":"build-2784847793"},"reference-count":22,"publisher":"Journal of the ASEAN Federation of Endocrine Societies (JAFES)","issue":"2","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J ASEAN Fed Endocr Soc"],"abstract":"<jats:p>Background. Increasing use and abuse of antibiotics has led to a rise in multi-drug resistant organisms (MDRO) isolates among infected diabetic foot ulcers (DFUs) and is seen in more than half of all diabetic foot infection cases. This study aimed to identify risk factors for MDRO infection in DFUs since no Filipino studies are available to establish such association.\nMethodology. A cross-sectional, analytical study was conducted to evaluate risk factors for MDRO in DFUs. Adult patients admitted in a tertiary hospital from January 2019 - December 2023 for DFU were included in the study. Based on retrospective chart review, patients with DFU described to be infected with accompanying superficial or deep wound cultures were studied. Patients were classified under the MDRO-positive group if their cultures reported any of the following organisms: methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum beta-lactamases (ESBL), amp C and carbapenamases-producing Enterobacteriaceae, Metallo-beta-lactamases (MBL)-producing Pseudomonas, Acinetobacter species, or any isolate with at least one drug resistance in three different antibiotic classes. Those who did not fall into this definition, including cultures without growth, were classified under the MDRO-negative group. Clinical risk factors and pertinent laboratory findings were obtained from their data.\nResults. One hundred fifty-one (151) patients were included in the study and 52 (34.43%) patient had MDRO isolates. The most common isolates seen were Klebsiella pneumoniae for gram-negative organisms and Staphylococcus aureus for gram-positive organisms. For gram-negative isolates, erythromycin had the most resistance at 17.53% followed by oxacillin and clindamycin both at 13.4%. For gram-positive isolates, highest resistance were seen with ampicillin at 18.99% followed by cefuroxime at 13.57% and amoxicillin-clavulanate at 11.63%.\nHigher ulcer grade (Crude OR = 1.11 [95% CI 1.00 - 1.23], p-value 0.04; Crude OR = 1.29, [95% CI 1.04 - 1.60], p-value 0.02), as well as previous admission for diabetic foot ulcer (Crude OR = 2.28, [95% CI 1.10 to 4.73], p-value 0.04) were associated with multi-drug resistance. Logistic regression showed that only a previous admission had significant association for MDRO positivity (Adjusted OR = 3.00 [95% CI: 1.04 \u2013 8.62], p-value 0.04).\nConclusion. There is a high burden of multi-drug resistant organism infection in diabetic foot ulcers with significant association in higher ulcer grades. A previous admission for diabetic foot ulcer significantly increases the odds for MDRO infection in succeeding diabetic foot infections.<\/jats:p>","DOI":"10.15605\/jafes.041.02.6303","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:15:36Z","timestamp":1787904936000},"source":"Crossref","is-referenced-by-count":0,"title":["Risk Factors Associated with Multi-drug Resistant Organism (MDRO) Isolates in Infected Diabetic Foot Ulcers (DFU)"],"prefix":"10.15605","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1120-2624","authenticated-orcid":false,"given":"Athena Jan","family":"Patawaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daveric","family":"Pagsisihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6244","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"86983","unstructured":"1. Chomie EI, Nuneza OM. Clinical profile and prognosis of diabetes mellitus type 2 patients with diabetic foot ulcers in Chomi Medical and Surgical Clinic, General Santos City, Philippines. Int Res J Biol Sci. 2015;4(1):41-6."},{"key":"86984","doi-asserted-by":"crossref","unstructured":"2. Goh TC, Bajuri MY, Nadarajah SC, Abdul Rashid AH, Baharuddin S, Zamri KS. Clinical and bacteriological profile of diabetic foot infections in a tertiary care. J Foot Ankle Res. 2020;13(1):36. https:\/\/pubmed.ncbi.nlm.nih.gov\/32546270 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7298861 https:\/\/doi.org\/10.1186\/s13047-020-00406-y","DOI":"10.1186\/s13047-020-00406-y"},{"key":"86985","doi-asserted-by":"crossref","unstructured":"3. Sugandhi P, Prasanth D. Emergence of multi drug resistance strains causing diabetic foot infection in Salem, Tamil Nadu, India. Int J Diabetes Dev Ctries. 2018;38(1):100-7. https:\/\/doi.org\/10.1007\/s13410-017-0555-4","DOI":"10.1007\/s13410-017-0555-4"},{"key":"86986","doi-asserted-by":"crossref","unstructured":"4. Trivedi U, Parameswaran S, Armstrong A, et al. Prevalence of multiple antibiotic resistant infections in diabetic versus nondiabetic wounds. J Pathog. 2014;2014:173053. https:\/\/pubmed.ncbi.nlm.nih.gov\/25054067 Phttps:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4099163 https:\/\/doi.org\/10.1155\/2014\/173053","DOI":"10.1155\/2014\/173053"},{"key":"86987","doi-asserted-by":"crossref","unstructured":"5. Jain SK, Barman R. Bacteriological profile of diabetic foot ulcer with special reference to drug-resistant strains in a tertiary care center in North-East India. Indian J Endocrinol Metab. 2017;21(5):688-94. https:\/\/pubmed.ncbi.nlm.nih.gov\/28989875 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5628537 https:\/\/doi.org\/10.4103\/ijem.IJEM_546_16","DOI":"10.4103\/ijem.IJEM_546_16"},{"key":"86988","doi-asserted-by":"crossref","unstructured":"6. Schmidt BM, Ye W, Zhou S. Multidrug resistant organism predicts ulcer recurrence following surgical management of diabetic foot osteomyelitis. Int Wound J. 2020;17(6):1634-41. https:\/\/pubmed.ncbi.nlm.nih.gov\/32633880 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7736527 https:\/\/doi.org\/10.1111\/iwj.13439","DOI":"10.1111\/iwj.13439"},{"key":"86989","doi-asserted-by":"crossref","unstructured":"7. Henig O, Pogue JM, Martin E, et al. The impact of multidrug-resistant organisms on outcomes in patients with diabetic foot infections. Open Forum Infect Dis. 2020;7(5):ofaa161. https:\/\/pubmed.ncbi.nlm.nih.gov\/32500092 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7255643 https:\/\/doi.org\/10.1093\/ofid\/ofaa161","DOI":"10.1093\/ofid\/ofaa161"},{"key":"86990","doi-asserted-by":"crossref","unstructured":"8. Kathirvel M, Prabakaran V, Jayarajan J, Sivakumar A, Govindan V. Risk factors for the diabetic foot infection with multidrug-resistant microorganisms in South India. Int Surg J. 2018;5(2):675-82. https:\/\/doi.org\/10.18203\/2349-2902.isj20180374","DOI":"10.18203\/2349-2902.isj20180374"},{"key":"86991","doi-asserted-by":"crossref","unstructured":"9. Datta P, Chander J, Gupta V, Mohi GK, Attri AK. Evaluation of various risk factors associated with multidrug-resistant organisms isolated from diabetic foot ulcer patients. J Lab Physicians. 2019;11(1):58-62. https:\/\/pubmed.ncbi.nlm.nih.gov\/30983804 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6437817 https:\/\/doi.org\/10.4103\/JLP.JLP_106_18","DOI":"10.4103\/JLP.JLP_106_18"},{"key":"86992","doi-asserted-by":"crossref","unstructured":"10. Liu X, Ren Q, Zhai Y, Kong Y, Chen D, Chang B. Risk factors for multidrug-resistant organisms infection in diabetic foot ulcer. Infect Drug Resist. 2022;15:1627-35. https:\/\/pubmed.ncbi.nlm.nih.gov\/35418765 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8999704 https:\/\/doi.org\/10.2147\/IDR.S359157","DOI":"10.2147\/IDR.S359157"},{"key":"86993","doi-asserted-by":"crossref","unstructured":"11. Yan X, Song JF, Zhang L, Xia L. Analysis of risk factors for multi-drug resistant organisms in diabetic foot ulcers. BMC Endocr Disord. 2022;22(1):46. https:\/\/pubmed.ncbi.nlm.nih.gov\/35189877 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8862361 https:\/\/doi.org\/10.1186\/s12902-022-00957-0","DOI":"10.1186\/s12902-022-00957-0"},{"key":"86994","doi-asserted-by":"crossref","unstructured":"12. Dai JD, Jiang C, Chen H, Chai Y. Assessment of the risk factors of multidrug- resistant organism infection in adults with type 1 or type 2 diabetes and diabetic foot ulcer. Can J Diabetes. 2020;44(4):342-9. https:\/\/pubmed.ncbi.nlm.nih.gov\/32005564 https:\/\/doi.org\/10.1016\/j.jcjd.2019.10.009","DOI":"10.1016\/j.jcjd.2019.10.009"},{"key":"86995","doi-asserted-by":"crossref","unstructured":"13. Matta-Gutie\u0301rrez G, Garci\u0301a-Morales E, Garci\u0301a-A\u0301lvarez Y, A\u0301lvaro-Afonso FJ, Molines-Barroso RJ, La\u0301zaro-Marti\u0301nez JL. The influence of multidrug-resistant bacteria on clinical outcomes of diabetic foot ulcers: A systematic review. J Clin Med. 2021;10(9):1948. https:\/\/pubmed.ncbi.nlm.nih.gov\/34062775 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8124692 https:\/\/doi.org\/10.3390\/jcm10091948","DOI":"10.3390\/jcm10091948"},{"key":"86996","doi-asserted-by":"crossref","unstructured":"14. Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998;17(14):1623-34. https:\/\/pubmed.ncbi.nlm.nih.gov\/9699234 https:\/\/doi.org\/10.1002\/(sici)1097-0258(19980730)17:14<1623::aid-sim871>3.0.co;2-s","DOI":"10.1002\/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S"},{"key":"86997","doi-asserted-by":"crossref","unstructured":"15. Senneville \u00c9, Albalawi Z, van Asten SA, et al. IWGDF\/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections. International Working Group on the Diabetic Foot; 2023. https:\/\/iwgdfguidelines.org\/wp-content\/uploads\/2023\/07\/IWGDF-2023-04-Infection-Guideline.pdf","DOI":"10.1093\/cid\/ciad527"},{"key":"86998","doi-asserted-by":"crossref","unstructured":"16. Alahakoon C, Fernando M, Galappaththy C, et al. Repeatability, completion time, and predictive ability of four diabetes-related foot ulcer classification systems. J Diabetes Sci Technol. 2023;17(1):35-41. https:\/\/pubmed.ncbi.nlm.nih.gov\/33451251 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC9846411 https:\/\/doi.org\/10.1177\/1932296820986548","DOI":"10.1177\/1932296820986548"},{"key":"86999","doi-asserted-by":"crossref","unstructured":"17. Saltoglu N, Ergonul O, Tulek N, et al. Influence of multidrug resistant organisms on the outcome of diabetic foot infection. Int J Infect Dis. 2018;70:10-4. https:\/\/pubmed.ncbi.nlm.nih.gov\/29476898 https:\/\/doi.org\/10.1016\/j.ijid.2018.02.013","DOI":"10.1016\/j.ijid.2018.02.013"},{"key":"87000","unstructured":"18. Alcantara AS, Araza L, Mercado-Asis L, Tan-Alora A. Bacterial infections among Filipino diabetics at the Santo Tomas University Hospital. Philipp J Microbiol Infect Dis. 1999;28(3):91-7."},{"key":"87001","doi-asserted-by":"crossref","unstructured":"19. Zubair M, Ahmad J. Potential risk factors and outcomes of infection with multidrug resistance among diabetic patients having ulcers: 7 years study. Diabetes Metab Syndr. 2019;13(1):414-8. https:\/\/pubmed.ncbi.nlm.nih.gov\/30641735 https:\/\/doi.org\/10.1016\/j.dsx.2018.10.014","DOI":"10.1016\/j.dsx.2018.10.014"},{"key":"87002","doi-asserted-by":"crossref","unstructured":"20. Ji X, Jin P, Chu Y, Feng S, Wang P. Clinical characteristics and risk factors of diabetic foot ulcer with multidrug-resistant organism infection. Int J Low Extrem Wounds. 2014;13(1):64-71. https:\/\/pubmed.ncbi.nlm.nih.gov\/24520007 https:\/\/doi.org\/10.1177\/1534734614521236","DOI":"10.1177\/1534734614521236"},{"key":"87003","doi-asserted-by":"crossref","unstructured":"21. Monteiro-Soares M, Russell D, Boyko EJ, et al. Guidelines on the classification of diabetic foot ulcers (IWGDF 2019). Diabetes Metab Res Rev. 2020;36(suppl 1):e3273. https:\/\/pubmed.ncbi.nlm.nih.gov\/32176445 https:\/\/doi.org\/10.1002\/dmrr.3273","DOI":"10.1002\/dmrr.3273"},{"key":"87004","doi-asserted-by":"crossref","unstructured":"22. Chuan F, Tang K, Jiang P, Zhou B, He X. Reliability and validity of the perfusion, extent, depth, infection and sensation (PEDIS) classification system and score in patients with diabetic foot ulcer. PLoS One. 2015;10(4):e0124739. https:\/\/pubmed.ncbi.nlm.nih.gov\/25875097 https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4395335 https:\/\/doi.org\/10.1371\/journal.pone.0124739","DOI":"10.1371\/journal.pone.0124739"}],"container-title":["Journal of the ASEAN Federation of Endocrine Societies"],"original-title":[],"link":[{"URL":"https:\/\/asean-endocrinejournal.org\/index.php\/JAFES\/article\/download\/6303\/5353","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/asean-endocrinejournal.org\/index.php\/JAFES\/article\/download\/6303\/5353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:15:41Z","timestamp":1787904941000},"score":1,"resource":{"primary":{"URL":"https:\/\/asean-endocrinejournal.org\/index.php\/JAFES\/article\/view\/6303"}},"subtitle":["An Analytical Cross-sectional Study"],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,8,6]]}},"URL":"https:\/\/doi.org\/10.15605\/jafes.041.02.6303","relation":{},"ISSN":["2308-118X","0857-1074"],"issn-type":[{"value":"2308-118X","type":"electronic"},{"value":"0857-1074","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,25]]}}}